One on One DIA 2021 – Clinical Ink (Ed Seguine)

Thought Leader:

Ed Seguine, CEO, Clinical Ink

June 25, 2021      

Ed Seguine identifies areas of importance to consider when thinking about patients and sites in totality as well as how technology can support complex protocol design.

Post a Comment

You must be logged in to post a Comment.